Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 405.8% | 95,989.5% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | -88.3% | -60.7% | -840.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -1,208.4% | -2,229.2% | -693,999.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -1,147.9% | -2,437.4% | -265,088.6% |
| EPS Diluted | -5.69 | -4.83 | -3.54 | -0.35 |
| % Growth | -17.8% | -36.4% | -911.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |